Position
GenTrust, LLC in Neurocrine Biosciences Inc
Back to the book · All holders of NBIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$17.8K$141.83 → $131.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.76K | $249.6K | — | — | — | 0.0% |
| Q1 2026 | 2.54K | $334.8K | $131.74 | −$17.8K | $102.9K | 0.0% |